Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion

Immunotherapy

Volumn 3, Issue 2, 2011, Pages 177-179

  Gilham, David E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

adoptive transfer; lymphodepletion; T cell; Toll like receptor; toxicity; vaccination

Indexed keywords

CYTOKINE; IMIQUIMOD; INTERLEUKIN 2; TOLL LIKE RECEPTOR 7;

ADOPTIVE TRANSFER; ARTICLE; AUTOIMMUNITY; CANCER THERAPY; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CELL THERAPY; ENGRAFTMENT; HUMAN; IMMUNE SYSTEM; INFECTION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE; VACCINATION;

EID: 79951755944     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.10.115     Document Type: Article

References (12)

1. Brenner MK, Heslop HE: Adoptive T-cell therapy of cancer. Curr. Opin. Immunol. 22, 251-257 (2010).
2. Rosenberg SA, Dudley ME: Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr. Opin. Immunol. 21, 233-240 (2009).
3. Besser MJ, Shapira-Frommer R, Treves AJ et al.: Clinical responses in a Phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin. Cancer Res. 16, 2646-2655 (2010).
4. DiGiusto DL, Cooper LJ: Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials. Cytotherapy 9, 613-629 (2007). (Pubitemid 47604651)
5. Dudley ME, Yang JC, Sherry R et al.: Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J. Clin. Oncol. 26, 5233-5239 (2008).
6. Gattinoni L, Finkelstein SE, Klebanoff CA et al.: Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J. Exp. Med. 202, 907-912 (2005). (Pubitemid 41396891)
7. Robbins PF, Dudley ME, Wunderlich J et al.: Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J. Immunol. 173, 7125-7130 (2004). (Pubitemid 39628146)
8. Ly LV, Sluijter M, Versluis M et al.: Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res. 70, 8339-8346 (2010).
9. Palmer DC, Balasubramaniam S, Hanada K et al.: Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction. J. Immunol. 173, 7209-7216 (2004). (Pubitemid 39628156)
10. Hawkins RE, Gilham DE, Debets R et al.: Development of adoptive cell therapy for cancer: a clinical perspective. Hum. Gene Ther. 21, 665-672 (2010).
11. Wallen H, Thompson JA, Reilly JZ, Rodmyre RM, Cao J, Yee C: Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. PLoS One 4, E4749 (2009).
12. Hunder NN, Wallen H, Cao J et al.: Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N. Engl. J. Med. 358, 2698-2703 (2008). (Pubitemid 351860862)